Cargando…
Multi-Site Clinical Evaluation of DW-MRI as a Treatment Response Metric for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
PURPOSE: To evaluate diffusion weighted MRI (DW-MR) as a response metric for assessment of neoadjuvant chemotherapy (NAC) in patients with primary breast cancer using prospective multi-center trials which provided MR scans along with clinical outcome information. MATERIALS AND METHODS: A total of 39...
Autores principales: | Galbán, Craig J., Ma, Bing, Malyarenko, Dariya, Pickles, Martin D., Heist, Kevin, Henry, Norah L., Schott, Anne F., Neal, Colleen H., Hylton, Nola M., Rehemtulla, Alnawaz, Johnson, Timothy D., Meyer, Charles R., Chenevert, Thomas L., Turnbull, Lindsay W., Ross, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376686/ https://www.ncbi.nlm.nih.gov/pubmed/25816249 http://dx.doi.org/10.1371/journal.pone.0122151 |
Ejemplares similares
-
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
por: Galbán, Stefanie, et al.
Publicado: (2012) -
Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response Trial
por: Newitt, David C., et al.
Publicado: (2020) -
Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
por: Lemasson, Benjamin, et al.
Publicado: (2016) -
Repeatability of Quantitative Magnetic Resonance Imaging Biomarkers in the Tibia Bone Marrow of a Murine Myelofibrosis Model
por: Ross, Brian D., et al.
Publicado: (2023) -
Comparison of Voxel-Wise and Histogram Analyses of Glioma ADC Maps for Prediction of Early Therapeutic Change
por: Chenevert, Thomas L., et al.
Publicado: (2019)